BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12737373)

  • 1. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.
    Blendis L; Wong F
    Clin Med (Lond); 2003; 3(2):154-9. PubMed ID: 12737373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of refractory ascites and hepatorenal syndrome.
    Chutaputti A
    J Gastroenterol Hepatol; 2002 Apr; 17(4):456-61. PubMed ID: 11982727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Arroyo V
    Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascites and hepatorenal syndrome: pathophysiology and management.
    Roberts LR; Kamath PS
    Mayo Clin Proc; 1996 Sep; 71(9):874-81. PubMed ID: 8790265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on ascites and hepatorenal syndrome.
    Gentilini P; Vizzutti F; Gentilini A; Zipoli M; Foschi M; Romanelli RG
    Dig Liver Dis; 2002 Aug; 34(8):592-605. PubMed ID: 12502217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M; Gerbes AL
    Gut; 2010 Jul; 59(7):988-1000. PubMed ID: 20581246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and treatment of ascites and the hepatorenal syndrome.
    Gentilini P; Laffi G
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):581-607. PubMed ID: 1421601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatorenal syndrome and ascites--questions and answers.
    Bernardi M; Blendis L; Burroughs AK; Laffi G; Rodes J; Gentilini P
    Liver; 1999; 19(1 Suppl):15-74. PubMed ID: 10227000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.